TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
3 hedge funds and large institutions have $330K invested in TITAN PHARMACEUTICAL INC in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
49% more capital invested
Capital invested by funds: $221K → $330K (+$108K)
0% more funds holding
Funds holding: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$6.07K |
Top Sellers
TTP Hedge Fund Activity: Q3 2013 in Review
3 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q3 2013, worth a combined $330K — up 49% from $221K a quarter earlier.
Fund positioning in TTP was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Gagnon Securities, adding an estimated $6.07K.
- 3 institutional investors held TITAN PHARMACEUTICAL INC (TTP) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $330K of TITAN PHARMACEUTICAL INC stock for Q3 2013, up 49% quarter-over-quarter.
- 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q3 2013 and 0 closed out.
- The largest TITAN PHARMACEUTICAL INC buyer in Q3 2013 was Gagnon Securities, an estimated $6.07K added.
Based on aggregated 13F filings for Q3 2013.